secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001493152-24-004350
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed elects stock payment of $4.7M fees from Lucid Diagnostics
----------------------------------------------------------------

- PAVmed received $4,675,256 of fees/reimbursements from Lucid Diagnostics via 3,331,771 shares of Lucid common stock.
- Lucid Diagnostics is a majority-owned subsidiary of PAVmed.
- Transaction described in more detail in Lucid Diagnostics' Form 8-K filed January 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224004350/0001493152-24-004350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224004350/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer